Back to VANGUARD GROUP INC VANGUARD GROUP INC

ELDNELDN
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in ELEDON PHARMACEUTICALS INC

VANGUARD GROUP INC holds 4M shares of ELDN (ELEDON PHARMACEUTICALS INC), worth $6.1M as of 2025-Q4. The position was increased (+23.6% shares). ELDN represents 0.0% of VANGUARD GROUP INC's portfolio.

Current Value

$6.1M

Current Shares

4M

Total Value Change

+$2.2M

Total Shares Change

+2.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
4M
+23.6%
$6.1M0.0%$1.51
33
2025-Q3
Decreased
3.3M
-1.5%
$8.5M0.0%$2.54
0
2025-Q2
Increased
3.3M
+12.4%
$9M0.0%$2.69
31
2025-Q1
Increased
3M
+2.0%
$10M0.0%$3.35
28
2024-Q4
Increased
2.9M
+84.9%
$11.9M0.0%$4.14
43
2024-Q3
New
1.6M
-
$3.9M0.0%$2.49
37

Other major holders of ELDN: BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used